MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline INCR Q2 2023 Earnings EPS Surges Past Estimates as Company Delivers Strong Operational Results PSNYW Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Challenges for Polestar XRN Q1 2026 Earnings Disappointing Quarter as EPS Misses Estimates Significantly WYFI Q1 2026 Earnings EPS Misses Estimates Stock Climbs 4 BCDA Q1 2026 Earnings EPS Misses Estimates as No Revenue Reported Stock Edges Higher KTB Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher IIPR Q1 2026 Earnings EPS Misses Estimates Amid Persistent Cannabis Sector Headwinds FCPT Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher THCH Q4 2025 Earnings Deepening Losses Amid Growth Push Tonix Pharmaceuticals Q1 2026 Earnings WiderThanExpected Loss Compounds Investor Concerns Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment